Results 281 to 290 of about 17,703,275 (296)
Some of the next articles are maybe not open access.
Functional significance of VEGFR‐2 on ovarian cancer cells
International Journal of Cancer, 2009Whitney A Spannuth +2 more
exaly
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
European Journal of Medicinal Chemistry, 2014Maria Leticia De Castro Barbosa +2 more
exaly
Comparative Structure‐Function Analysis of VEGFR‐1 and VEGFR‐2
Annals of the New York Academy of Sciences, 2003Rosana D Meyer, Nader Rahimi
exaly
VEGFR-2 expression in tumor tissue of breast cancer patients
Doklady Biological Sciences, 2010A A, Lushnikova +4 more
openaire +2 more sources
Cardiovascular safety liabilities of VEGFR-2 inhibitors
The identification of the vascular endothelial growth factor (VEGF) as a crucial determinant in neoangiogenesis, as well as the role of its overexpression in tumour growth and dissemination, have provided an attractive target for more specific cancer treatments. In particular, since the clinical approval of the first receptor tyrosine kinase inhibitor (openaire +1 more source
Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
European Journal of Medicinal Chemistry, 2010Ki-Woong Jeong +2 more
exaly